FASTing-like Approach and Maintenance IMMunotherapy in ES-SCLC Patients Not Progressing on Chemoimmunotherapy Induction

Condition:   Small Cell Lung Carcinoma Interventions:   Dietary Supplement: Cyclic, 5-day calorie restriction;   Drug: Atezolizumab Sponsors:   Fondazione IRCCS Istituto Nazionale dei Tumori, Milano;   IFOM, The FIRC Institute of Molecular Oncology;   University of Milan Not yet recruiting

Source: ClinicalTrials.gov - January 30, 2023 Category: Research Source Type: clinical trials